Wednesday, April 23, 2008

Patients' Employment Rights Bill Moves to Assembly Floor for a Vote!!!!

***Urge Your State Assembly Member to Support AB 2279!***

Dear ASA Supporter,

Last week, Americans for Safe Access (ASA) and the state legislature moved
another step further towards securing employment rights for California medical
marijuana patients. The Assembly Labor Committee passed AB 2279 on a 6-2 vote.
AB 2279, authored by Assemblymember Mark Leno and sponsored by ASA, now moves
to the assembly floor and we need you to urge your assembly member to support
medical cannabis patients' rights!

The California Supreme Court ruled in Ross v. RagingWire that an employee using
medical marijuana with a doctor's recommendation may be fired solely because of
his/her status as a medical cannabis patient. Now, it's up to the legislature
to pass AB 2279 to protect California patients' right to work.

After passing both the Assembly Judiciary and Labor Committees, AB 2279 could
reach the California Assembly floor as soon as next week!

ASA staff, working with other organizations, unions, and advocates, will be
working hard over the next several days to educate state legislators about this
important bill. We need your help today to ensure passage! Here are three
things you can do to secure California patients' right to work:

1. Contact your assembly member at
to urge him/her to vote
yes on AB 2279. The only way this bill will pass is if the legislators hear
from their constituents (you!)

2. Forward this email to every California medical cannabis supporter you know
and ask them to take action.

3. Visit to donate to ASA to
support our efforts in Sacramento.

Thank you for supporting ASA and our efforts to secure the rights of California
medical marijuana patients.


Don Duncan
California Director
Americans for Safe Access

Americans for Safe Access is the nation's largest organization of patients,
medical professionals, scientists and concerned citizens promoting safe and
legal access to cannabis for therapeutic use and research.

No comments: